Skip to contentZ
Zomedica Corp.
Z
ZOMDFZomedica Corp. Q2 2020 · 10-Q
Revenue$0.00$0.00no prior Q2 2019 on file Net Income-$5.31M-$5.31MN/M vs Q2 2019 EPS Diluted-$0.02-$0.02N/M vs Q2 2019 The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Zomedica Corp. · CIK 1684144 · Engraved from SEC EDGAR
Operating Cash Flow-$5,720,528N/M ended Jun 30, 2020 · filed Aug 10, 2020 · 41 d after period end